Robert J. Laffan
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Cellular and Molecular Neuroscience top 10%
- Nutrition and Dietetics top 10%
- Physiology
- Co-authors
- Bernard RubinM.E. GoldbergJohn P. HighDale B. EvansThomas SchaefferRobert J. LeeMichael J. AntonaccioMorton E. Goldberg
- Topics
- Protein Hydrolysis and Bioactive Peptides (4 papers)Renin-Angiotensin System Studies (3 papers)Pharmacogenetics and Drug Metabolism (2 papers)
- Journals
- Journal of Pharmacology and Experimental TherapeuticsCardiovascular ResearchEuropean Journal of Pharmacology
- Partner nations
- MalaysiaSwedenUnited States
In The Last Decade
Robert J. Laffan
15 papers receiving 581 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 390
- Cardiology and Cardiovascular Medicine 338
- Cellular and Molecular Neuroscience 133
- Nutrition and Dietetics 119
- Physiology 84
Countries citing papers authored by Robert J. Laffan
This map shows the geographic impact of Robert J. Laffan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Laffan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Laffan more than expected).
Fields of papers citing papers by Robert J. Laffan
This network shows the impact of papers produced by Robert J. Laffan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Laffan. The network helps show where Robert J. Laffan may publish in the future.
Co-authorship network of co-authors of Robert J. Laffan
This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Laffan. A scholar is included among the top collaborators of Robert J. Laffan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Laffan. Robert J. Laffan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium. | 5 |
| 2 | 83 | |
| 3 | 183 | |
| 4 | 52 | |
| 5 | 31 | |
| 6 | 148 | |
| 7 | 26 | |
| 8 | 80 | |
| 9 | 32 | |
| 10 | 19 | |
| 11 | 3 | |
| 12 | 5 | |
| 13 | 0 | |
| 14 | 7 | |
| 15 | 37 | |
| 16 | Stimulus intensity, maximal electroshock seizures, and potency of anticonvulsants in rats. | 6 |
About Robert J. Laffan
Robert J. Laffan is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 717 indexed citations. Recurring topics across this work include Protein Hydrolysis and Bioactive Peptides (4 papers), Renin-Angiotensin System Studies (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (338 citations), Medical Terminology (2 citations) and Nutrition and Dietetics (119 citations). Robert J. Laffan has collaborated with scholars based in Malaysia, Sweden and United States. Frequent co-authors include Bernard Rubin, M.E. Goldberg, John P. High, Dale B. Evans, Thomas Schaeffer, Robert J. Lee, Michael J. Antonaccio, Morton E. Goldberg, Don N. Harris and Herbert L. Borison. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Cardiovascular Research and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.